RecruitingNCT00599092

Pituitary Tumor Surveillance: Pathogenic Correlation

Pituitary Tumor Surveillance: Pathogenetic Correlation


Sponsor

Cedars-Sinai Medical Center

Enrollment

1,250 participants

Start Date

Jan 1, 1997

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study monitors patients with pituitary tumors (abnormal growths on the small hormone-producing gland at the base of the brain) over time to understand which tumors grow, which stay stable, and what biological factors predict their behavior. **You may be eligible if...** - You have been diagnosed with a pituitary adenoma (a usually non-cancerous tumor of the pituitary gland) - You are under active surveillance or treatment for a pituitary tumor - You are willing to provide blood samples and undergo regular MRI scans **You may NOT be eligible if...** - Your pituitary tumor has been fully removed and you are no longer being monitored - You have a metal implant or other contraindication to MRI scanning - You are unable or unwilling to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Cedars-Sinai Medical Center, Pituitary Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00599092


Related Trials